Seres Therapeutics, Inc. ($MCRB)
Filing Information
| Accession Number | 0001193125-26-355712 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 18, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
572
Total Value
$373.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Legal Officer | Common Stock | โ | Aug 15, 2026 | Exercise/Conversion | 245 | โ | โ | 8,199 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Common Stock | โ | Aug 17, 2026 | Sale | 82 | $4.55 | $373.10 | 8,117 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Restricted Stock Units | Derivative | Aug 15, 2026 | Exercise/Conversion | 133 | $0.00 | $0.00 | 265 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Restricted Stock Units | Derivative | Aug 15, 2026 | Exercise/Conversion | 112 | $0.00 | $0.00 | 667 | Direct | โ | View Details |